Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Cantón, , Urbano,
DOB: 01-APR-1945 (Age: 80)
Gender: male
Address:
Vial Vito Trujillo 29 Piso 2
38001 Santa Cruz de Tenerife (Spain)
ID: 8854-480268-4 (ECI)
Report
Date: 08-APR-2025
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Centro de Salud Ruiz de Padrón
(Spain)
Specimen
Collected: 08-APR-2025

Chemistry

Test 08-APR-2025 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.4 4.5 - 6.4 %
Glucose [Mass/volume] in Blood 88.0 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 16.4 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 0.6 L 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.1 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 140.7 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.9 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 104.9 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 24.0 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 298.8 H 100 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 136.0 45 - 175 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 209.8 H 0 - 190 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 61.8 40 - 100 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 2.8 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Laboratory results are largely within normal limits, except for mildly decreased creatinine, which is not clinically significant, and elevated total and LDL cholesterol, indicating increased cardiovascular risk. Glucose control is adequate, and kidney function and electrolytes are stable. Recommend addressing hypercholesterolemia with the treating physician.